Objectives There is no systematic review on economic evaluations of telemedicine in Japan, despite over 1000 trials implemented. Our systematic review aims to examine whether Japan’s telemedicine is cost-saving or cost-effective, examine the methodological rigorousness of the economic evaluations, and discuss future studies needed to improve telemedicine’s financial sustainability.
Methods We searched five databases, including two Japanese databases, to find peer-reviewed articles published between January 1, 2000 and December 31, 2014 in English and Japanese that performed economic evaluations of Japan’s telemedicine programs. The methodological rigorousness of the economic analyses was assessed with a well-established checklist. We calculated the benefit-to-cost ratio (BCR) when a reviewed study reported related data but did not report the BCR. All cost values were adjusted to 2014 US dollars.
Results Among the 17 articles identified, six studies reported on settings connecting physicians for specialist consultations, and eleven studies on settings connecting healthcare providers and patients at home. There are three cost-benefit analyses and three cost-minimization analyses. The remaining studies measured the benefit of telemedicine only, using medical expenditure saved or users’ willingness-to-pay. There was substantial diversity in the methodological rigorousness. Studies on teledermatology and teleradiology indicated a favorable level of economic efficiency. Studies on telehomecare gave mixed results. One cost-benefit analysis on telehomecare indicated a low economic efficiency, partly due to public subsidy rules, e.g., a too short budget period.
Conclusions Overall, telemedicine programs in Japan were indicated to have a favorable level of economic efficiency. However, the scarcity of the economic literature indicates the need for further rigorous economic evaluation studies.
Summary
Citations
Citations to this article as recorded by
Key Factors Influencing the Operationalization and Effectiveness of Telemedicine Services in Henan Province, China: Cross-Sectional Analysis Xianying He, Fangfang Cui, Minzhao Lyu, Dongxu Sun, Xu Zhang, Jinming Shi, Yinglan Zhang, Shuai Jiang, Jie Zhao Journal of Medical Internet Research.2024; 26: e45020. CrossRef
Analysis of the Forces Driving Public Hospitals’ Operating Costs Using LMDI Decomposition: The Case of Japan Kiyotoshi Kou, Yi Dou, Ichiro Arai Sustainability.2024; 16(2): 853. CrossRef
Remote consultations in community mental health: A qualitative study of clinical teams Robyn McCarron, Anna Moore, Ilana Foreman, Emily Brewis, Olivia Clarke, Abby Howes, Katherine Parkin, Diana Luk, Maisie Satchwell Hirst, Emilie Sach, Aimee Shipp, Lorna Stahly, Anupam Bhardwaj Journal of Psychiatric and Mental Health Nursing.2024; 31(5): 857. CrossRef
Relationship Between Clinics Offering Telemedicine and Population Density in Japan: An Ecological Study Takashi Kuwayama, Kazuhiko Kotani Telemedicine Reports.2024; 5(1): 99. CrossRef
A Study of Factors Influencing the Acceptance of non-Face-to-Face Treatment Based on Social Cognitive Theory Myung Soon Kwon, Ji Hye Jang, Hyun Sik Kim, Yeon Jeong Heo Quality Improvement in Health Care.2024; 30(1): 55. CrossRef
Multi-Dimensional Analysis of Japanese Telemedicine Patient Satisfaction Andrew N Mason, Toshio Naito, Shinichi Fukushima, Keiko Asano, Ken Yamaji, Ryohei Kuwatsuru Health Services Insights.2024;[Epub] CrossRef
Case study of a healthcare virtual community model Kun-Huang Huarng, Cheng-Fang Lee, Tiffany Hui-Kuang Yu Technological Forecasting and Social Change.2023; 188: 122281. CrossRef
COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19 Shigeru Shibata, Kazuo Kobayashi, Masami Tanaka, Kei Asayama, Eiichiro Yamamoto, Hironori Nakagami, Satoshi Hoshide, Takuya Kishi, Chisa Matsumoto, Masaki Mogi, Satoshi Morimoto, Koichi Yamamoto, Masashi Mukoyama, Kazuomi Kario, Koichi Node, Hiromi Rakugi Hypertension Research.2023; 46(3): 589. CrossRef
The Twenty Factors that Made Teledermatology Consultation a Matured Application: A Systematic Review Garehatty Rudrappa Kanthraj Clinical Dermatology Review.2023; 7(1): 10. CrossRef
Applications, opportunities, and challenges in using Telehealth for burn injury management: A systematic review Mohammad Hosein Hayavi-Haghighi, Jahanpour Alipour Burns.2023; 49(6): 1237. CrossRef
Economic evaluation of remote patient monitoring and organizational analysis according to patient involvement: a scoping review Myriam Le Goff-Pronost, Isabelle Bongiovanni-Delarozière International Journal of Technology Assessment in Health Care.2023;[Epub] CrossRef
Acceptability and feasibility of assisted telepsychiatry in routine healthcare settings in India: a qualitative study Abhijit Nadkarni, Ankur Garg, Ravindra Agrawal, Seema Sambari, Kedar Mirchandani, Richard Velleman, Devika Gupta, Urvita Bhatia, Godwin Fernandes, Ethel D’souza, Akshada Amonkar, Anil Rane Oxford Open Digital Health.2023;[Epub] CrossRef
Beyond the Nuts and Bolts: Tele-Critical Care Patients, Workflows, and Activity Patterns Christina Canfield, Silvia Perez-Protto, Matthew Siuba, Steven Hata, Chiedozie Udeh Telemedicine and e-Health.2022; 28(1): 73. CrossRef
Effectiveness of Pediatric Teleconsultation to Prevent Skin Conditions in Infants and Reduce Parenting Stress in Mothers: Randomized Controlled Trial Tomohisa Ando, Rintaro Mori, Kenji Takehara, Mari Asukata, Shuichi Ito, Akira Oka JMIR Pediatrics and Parenting.2022; 5(1): e27615. CrossRef
The Willingness to Pay for Telemedicine Among Patients With Chronic Diseases: Systematic Review Valerie Chua, Jin Hean Koh, Choon Huat Gerald Koh, Shilpa Tyagi Journal of Medical Internet Research.2022; 24(4): e33372. CrossRef
Telemedicine and Community Health Projects in Asia Anil Kumar Jha, Erika Sawka, Bhagirath Tiwari, Huiting Dong, Choon Chiat Oh, Seyedali Ghaemi, Xuejiao Zhang, Adarsh Kumar Jha Dermatologic Clinics.2021; 39(1): 23. CrossRef
A new telestroke network system in northern area of Okayama prefecture Ryo Sasaki, Toru Yamashita, Yoshio Omote, Mami Takemoto, Nozomi Hishikawa, Taijun Yunoki, Kazuki Kobayashi, Takashi Sawata, Yuki Sato, Junichi Kubota, Masayuki Mizobuchi, Takashi Hayashi, Koji Abe Neurology and Clinical Neuroscience.2021; 9(2): 166. CrossRef
Opportunities and challenges for contactless healthcare services in the post-COVID-19 Era Sang M. Lee, DonHee Lee Technological Forecasting and Social Change.2021; 167: 120712. CrossRef
Creation of a Learning Environment Contributing to the Development
of Communication Competencies within the System of Continuing Education of Medical Doctors NS Zhuravskaya, MV Bektasova, BV Okun’, VA Yanovich ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT.2021; : 95. CrossRef
Economic Aspects of Delivering Primary Care Services: An Evidence Synthesis to Inform Policy and Research Priorities LORCAN CLARKE, MICHAEL ANDERSON, ROB ANDERSON, MORTEN BONDE KLAUSEN, REBECCA FORMAN, JENNA KERNS, ADRIAN RABE, SØREN RUD KRISTENSEN, PAVLOS THEODORAKIS, JOSE VALDERAS, HANS KLUGE, ELIAS MOSSIALOS The Milbank Quarterly.2021; 99(4): 974. CrossRef
Knowledge Update on the Economic Evaluation of Pacemaker Telemonitoring Systems Antonio Lopez-Villegas, César Leal-Costa, Mercedes Perez-Heredia, Irene Villegas-Tripiana, Daniel Catalán-Matamoros International Journal of Environmental Research and Public Health.2021; 18(22): 12120. CrossRef
Problems of development of telemedicine technologies in Russia through the prism of foreign experience O. S. Kobyakova, F. N. Kadyrov National Health Care (Russia).2021; 2(2): 13. CrossRef
Economic evaluation of E-health interventions compared with alternative treatments in older persons’ care Aziz Rezapour, Seyede Sedighe Hosseinijebeli, Saeed Bagheri Faradonbeh Journal of Education and Health Promotion.2021; 10(1): 134. CrossRef
A Multicenter Case-Historical Control Study on Short-Term Outcomes of Tele-Intensive Care Unit Awad Al-Omari, Abbas Al Mutair, Maram Al Ammary, Fadi Aljamaan Telemedicine and e-Health.2020; 26(5): 645. CrossRef
Telemedicine in the OECD: An umbrella review of clinical and cost-effectiveness, patient experience and implementation Nkiruka D. Eze, Céu Mateus, Tiago Cravo Oliveira Hashiguchi, Hannah E. Carter PLOS ONE.2020; 15(8): e0237585. CrossRef
Understanding Medical Students’ Attitudes Toward Learning eHealth: Questionnaire Study Kjeld Vossen, Jan-Joost Rethans, Sander M J van Kuijk, Cees P van der Vleuten, Pieter L Kubben JMIR Medical Education.2020; 6(2): e17030. CrossRef
Тelemedicine technologies in occupational health and pathology Sergey A. Saiganov, Vadim I. Mazurov, Viktor V. Shilov, Sergey A. Gorbanev Hygiene and sanitation.2020; 99(9): 961. CrossRef
Barriers to use of remote monitoring technologies (RMT) used to support COVID-19 patients: A rapid review (Preprint) Elizabeth Houlding, Kedar Mate, Kim Engler, David Ortiz-Paredes, Marie-Pascale Pomey, Joseph Cox, Tarek Hijal, Bertrand Lebouché JMIR mHealth and uHealth.2020;[Epub] CrossRef
Feasibility of support vector machine learning in age‐related macular degeneration using small sample yielding sparse optical coherence tomography data Gwenolé Quellec, Jens Kowal, Pascal W. Hasler, Hendrik P. N. Scholl, Sandrine Zweifel, Balaskas Konstantinos, João Emanuel Ramos de Carvalho, Tjebo Heeren, Catherine Egan, Adnan Tufail, Peter M. Maloca Acta Ophthalmologica.2019;[Epub] CrossRef
Exploring the Impact of a Telehealth Care System on Organizational Capabilities and Organizational Performance from a Resource-Based Perspective Chun-Hsun Chen, Yu-Li Lan, Wei-Pang Yang, Fang-Ming Hsu, Chin-Lon Lin, Hsing-Chu Chen International Journal of Environmental Research and Public Health.2019; 16(20): 3988. CrossRef
Addressing cost and time barriers in chronic disease management through telemedicine: an exploratory research in select low- and middle-income countries Saleem Sayani, Momina Muzammil, Karima Saleh, Abdul Muqeet, Fabiha Zaidi, Tehniat Shaikh Therapeutic Advances in Chronic Disease.2019; 10: 204062231989158. CrossRef
Estado actual de la telemedicina: ¿dónde estamos y qué nos queda por hacer? Francesc García Cuyàs, Núria Vàzquez, Marc de San Pedro, Margarita Hospedales Medicina Clínica.2018; 150(4): 150. CrossRef
State of the art of the telemedicine. Where are we and what is pending to be done? Francesc García Cuyàs, Núria Vàzquez, Marc de San Pedro, Margarita Hospedales Medicina Clínica (English Edition).2018; 150(4): 150. CrossRef
Comparison between High- and Low-Cost Transmission of Tele-Anesthesia in Japan Yoh Sugawara, Tetsuya Miyashita, Yusuke Mizuno, Yusuke Nagamine, Tomoyuki Miyazaki, Ayako Kobayashi, Kentaro Tojo, Yasuhiro Iketani, Shunsuke Takaki, Takahisa Goto Journal of Healthcare Engineering.2018; 2018: 1. CrossRef
Comparative cost-benefit analysis of tele-homecare for community-dwelling elderly in Japan: Non-Government versus Government Supported Funding Models Miki Akiyama, Chon Abraham International Journal of Medical Informatics.2017; 104: 1. CrossRef
The use of telemedicine for delivering healthcare in Japan: Systematic review of literature published in Japanese and English languages Jun Ito, Sisira Edirippulige, Takeshi Aono, Nigel R Armfield Journal of Telemedicine and Telecare.2017; 23(10): 828. CrossRef
OBJECTIVES To estimate the value of statistical life (VSL) and health damage cost on theoretical mortality estimates due to environmental pollution. METHODS: We assessed the health risk on three environmental problems and eight sub-problems. Willingness to pay (WTP) was elucidated from a questionnaire survey with dichotomous contingent valuation method and VSL (which is the division of WTP by the change of risk reduction) calculated from WTP. Damage costs were estimated by multiplying VSL by the theoretical mortality estimates. RESULTS: VSLs from death caused by air pollution, indoor air pollution and drinking water contamination were about 0.3, 0.5 and 0.3 billion won, respectively. Damage costs of particulate matters (PM10) and radon were higher in the sub-problems and were above 100 billion won. Because damage cost depends on theoretical mortality estimate and WTP, its uncertainty is reduced in the estimating process. CONCLUSION: Health damage cost or risk benefit should be considered as one scientific criterion for decision making in environmental policy.
OBJECTIVE To evaluate the relative benefits and the costs associated with the introduction of the new pharmaceutical provision called 'Mandatory Prescription Syste m' which separates the role of physicians from that of pharmacists with respect to the prescription and dispensation of from the perspective of consumers (i.e., patients). METHODS: The costs of the system were measured by considering both direct and indirect costs. Direct costs included additional payments for ambulatory care and dispensing fees that occurred under the new system. Indirect costs consisted of transportation expenses and costs related to time spent for physician consultation, waiting for the prescriptions to be filled, and extra traveling. Benefits identified in this study were the reduction of drug misuse and overuse, and the overall decrease in drug consumption among the Korean population. Sensitivity analysis was performed for the inclusion of benefits for outpatients of hospitals, price elasticity, and increased fees for established patients. RESULTS: The net benefit was estimated to be about minus 1,862 billion won and the benefit-cost ratio was 0.478. This indicates that the costs of 'Mandatory Prescription' outweigh its benefits, relative to the previous system. The sensitivity analysis results for all the variables considered in this study consistently showed the benefit-cost ratio to be less than 1. CONCLUSION: The results of this study suggest that implementing Mandatory Prescription System in Korea might be inefficient from the consumer's perspective. The results of this study do not coincide with the results of previous studies, presumably because of the differences in study design and in which items of costs and benefits were considered.
OBJECTIVES Since 1991, nationwide massive neonatal screen-ing program for phenylketonuria (PKU) and congenital hypothyroidism have been performed in Korea. As in many other countries, efficiency of this program has not been definitely concluded. For the purpose of evaluation of this program, from the perspective of efficiency, a cost-benefit analysis was carried out. METHODS: Costs of the detection and the treatment program were compared with the projected benefit(avoided costs) that results from the prevention of the mental retardation associated with the disorders due to PKU and hypothyroidism. Costs and benefits were discounted at an annual rate of 5 %, and duration of life-long labor was assumed to be 30 years. Cost and benefit were estimated based on the detection rates of one case of PKU per 5,572 and one case of congenital hypothyroidism per 32,554 babies screened during 1991-1997. RESULTS: The benefit-cost ratio was 0.418. The sensitivity analysis for the discount rates and labor durations showed that most cost-benefit ratios were lower than one(1.0) except when discount rate was changed to 3% and detection rate to two- or threefold and/or labor duration to 40 years. CONCLUSIONS: The result of this study suggested that present program of mass screening for PKU and congenital hypothyroidism could not be justified in terms of efficiency. It doesn't coincide with the results of previous studies in major developed countries, presumably because of difference in detection rates and welfare cost for the disabled.
Although occupational low back pain accounts for 20~40% of all occupational illness and injury, there are limited numbers of studies regarding the effectiveness of back school program. The objective of this study was to evaluate the economic benefit of back school program for early return to work of occupational low back pain patients in the current occupational injury compensation and management system. The cost-benefit analysis in this study was conducted to evaluate the relative magnitude of benefit to cost. The total cost was estimated by calculating the value of components in back school program according to governmental budget protocol. The back school program was consisted of three major approaches, pain center, work-hardening program and functional restoration program and each of components had various facilities and experts. The total amount of cost was estimated as 250,866,220 won per year. The most promising type of back school program were quite intensive (a 3 to 5-week stay in a specialized center), therefore, if we adopted the 5-week stay course, 10 courses could be held in a year. Following to the medical act, 20 patients per doctor could participate in a each course, ie, total 200 patients in a year. As a result, we could estimate the cost of 1,254,331 won a patient. we estimated the benefit by using data of a few local labor offices about average medical treatment beneficiary and off-duty beneficiary of 46 occupational low back pain patients in 1994. Ullman and Larsson(1977) mentioned that the group of chronic low back pain patients who participated in back school program needed less time to recover by 48.4% of beneficiary duration. And in the trying to estimate the benefit, we asked 10 rehabilitation board certificate doctors about reduction proportion of treatment cost by introducing back school program. The answered reduction proportions were in the range of 30~45%, average 39%. As a final result, we could see that the introduction of back school program in treatment of chronic occupational low back pain patients could produce the benefit to cost ratio as 3.90 and 6.28. And we could conclude that the introduction of back school program was beneficial to current occupational injury compensation and management system.
Rubella is a viral disease with mild constitutional symptoms and generalized rashes ln childhood, it is an inconsequential illness, but when it occurs during early pregnant period, there are significant risks of heart defects, cataract, mental retardation to the fetus. The series of congenital defects induced by rubella is called 'congenital rubella syndrome'. Many research have been performed to find out more effective prevention program on rubella. The objectives of this study are, first, to calculate the incidence rate of acute rubella infection and congenital rubella syndrome in korea, second, to evaluate economic efficiency of several rubella vaccination policies and to offer data for the most reasonable decision on vaccination policy. Study populations are 663,312 children of one year-old in 1992. The author has performed cost-benefit analyses according to the three vaccination policies-U.S.A.'s. U.K's and Sweden's. In this study, the author got the incidence rate of acute rubella infection using the catalytic model. In the meantime, the author used 50 per 100,000 live births as the incidence rate of congenital rubella syndrome. The discount rate used in this study was 5 percent per annum. The sensitivity analyses were done with different discount rates (4%, 7%) and different incidence rate of congenital rubella syndrome (10,100 per 100,000 live births): The study results are as follows: 1. Without vaccination, lifetime expenditures per patient for acute rubella infection amount to 14,822 won and the total expenditures to about 3.1 billion won. Meanwhile, lifetime expenditures per patient for congenital rubella syndrome amount to about 91 million won and the total expenditures to about 16.3 billion won without vaccination. 2. The cost of vaccination for a child of one year old was 2,322 won and the total cost for the one year old children was about 1.5 billion won(American style). The cost for vaccination of female children at fifteen was about 339 million won (British style). And the cost of vaccination at one for both sex and female children at fifteen was about 1.9billion won (Swedish style). 3. The benefit to cost ratios of vaccination or female children at fifteen that is the british mode of rubella vaccination, was 60.0 at the level of 80 % population coverage and 48.6 at 100% coverage. It shows much higher benefit to cost ratio than those of the other two vaccination policies. 4. Both net benefits of vaccination at one (American style) and that of vaccinations at one and fifteen (Swedish style) range from about 17.0 billion to 17.8 billion won, those were larger than that of vaccinations of female children at fifteen(British style, about 16.0 billion). 5. In marginal cost-benefit analysis of only additional program or revaccination, the benefit to cost ratios were 3.6(80% coverage rate) or 0.6 (100% coverage rate). It implies that additional program was less efficient or inefficient 6. In sensitively analysis with different discount rates (4% or 7%) and different incidence rates of congenital rubella syndrome (l0 or 100 per 100,000 live births), the benefit to cost ratios has fluctuated in wide range. However, all the ratios of vaccination of female children at fifteen were higher than those of the others. Even under the most conservative assumption, the benefit to cost ratios of all the rubella vaccination policies were higher than 3.3. In conclusion all the rubella vaccination policies found to be cost-effective and particularly the vaccination of female children at fifteen was strongly recommended.